The life of a pet dog follows a predictable trajectory. “When you adopt a dog, you’re adopting future heartbreak,” said Emilie Adams, a New Yorker who owns three Rhodesian Ridgebacks. On Tuesday, the biotech company Loyal announced that it had moved one step closer to bringing one such drug to market. “The data you provided are sufficient to show that there is a reasonable expectation of effectiveness,” an official at the U.S. Food and Drug Administration informed the company in a recent letter. (Loyal provided a copy of the letter to The Times.)

---

Persons: ”, Emilie Adams, “ Organizations: New Yorker, Rhodesian, Loyal, U.S . Food, Drug Administration, Times Locations: New, U.S